Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study

Figure 2

Comparison of biomarkers significantly different between ACR responders and nonresponders for golimumab-treated patients. Mean ± SD comparison of biomarkers (log2 transformed) that were significantly different between ACR 20 and ACR 50 responders and nonresponders for golimumab-treated patients in the Training and Test Subsets.

Back to article page